Datar Cancer Genetics

Datar Cancer Genetics is a world-leading molecular oncology institution, equipped with fully-equipped laboratories, integrated process platforms, an in-house bioinformatics team, and a vast genetic database for precise and up-to-date reporting. The facility is accredited by NABL, ISO, CAP, and CLIA. Cancer research institutions both within and outside of China, as well as patients from around the world, including those from the United States, Switzerland, Germany, and the United Kingdom, have benefited from our services. With cutting-edge technology and years of extensive research, we offer effective treatment options for cancer patients who have failed multiple therapies. Our state-of-the-art cancer research center spans 40,000 square feet. We have a robust team of cancer researchers, doctors, scientists, and other technical staff, all educated and trained at top universities and institutes worldwide. Our entire team stands ready to assist clinicians and cancer patients, providing the most advanced treatment solutions for the most challenging cases.